> ImCheck Therapeutics named René Hoet, Ph.D., as CSO. Hoet joins the French biotech from Bayer, where he was responsible for antibody lead discovery. Statement
> Shares in Foamix jumped after it posted top-line data from a phase 3 trial of FMX101 in moderate-to-severe acne. Release
> ProQR Therapeutics raised $104 million in an underwritten public offering. Statement
> Valbiotis posted data from a phase 1/2 obesity trial. The company plans to advance the candidate into a larger study. Release
> Glythera rebranded as Iksuda Therapeutics as part of a shift from technology licensing to cancer drug development. Statement
> Innate Pharma enrolled the first patient in its IPH5401-Imfinzi combination trial. Release